61 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

3184

MicroBase Technology
NT$12.801.2%-20.0%NT$1.0bn/aPE43.1xn/a0%

6730

Lagis Enterprise
NT$45.009.6%13.6%NT$1.4bn/aPE31xn/a4.0%

4735

AViTA
NT$35.800%-8.2%NT$1.3bn/aPE30.7xn/a0%

4129

United Orthopedic
NT$98.10-1.0%82.7%NT$8.6bNT$118.50PE22.3xn/a2.3%

6879

TCI GENE
NT$81.800.4%-30.7%NT$2.2bn/aPE185.4xn/a2.4%

4106

Wellell
NT$28.400.5%-2.6%NT$2.9bn/aPE18.8xn/a3.0%

1786

SciVision Biotech
NT$95.005.2%43.3%NT$6.4bn/aPE36.2xn/a2.6%

1565

St.Shine OpticalLtd
NT$189.00-0.5%-26.6%NT$9.5bNT$197.00PE17.5xS5.8%3.7%

1733

Apex Biotechnology
NT$33.75-1.3%30.6%NT$3.4bn/aPE29.1xn/a3.3%

6782

Visco Vision
NT$228.50-9.5%-15.7%NT$14.4bNT$288.33PE47.7xE45.9%1.1%

4188

AmCad BioMed
NT$28.801.1%82.3%NT$1.5bn/aPS23.5xn/an/a

4736

TaiDoc Technology
NT$155.003.0%-16.7%NT$14.8bNT$161.00PE11.4xE-6.1%12.9%

3118

Level Biotechnology
NT$31.200.8%3.1%NT$1.0bn/aPE16.1xn/a5.4%

4150

Unicon Optical
NT$21.90-6.2%57.0%NT$3.2bn/aPS4.1xn/an/a

1799

Easywell Biomedicals
NT$69.0015.8%241.6%NT$8.4bn/aPS34.8xn/an/a

4724

Meribank Biotech
NT$37.95-3.6%n/aNT$2.4bn/aPS10.2xn/an/a

6518

Concord Medical
NT$25.20-1.4%-13.1%NT$840.0mn/aPE19.7xn/a4.0%

6499

Medeon Biodesign
NT$43.15-1.6%-23.2%NT$4.0bn/aPS20.2xn/a1.1%

6612

ICARES Medicus
NT$109.00-2.2%-13.5%NT$4.3bn/aPE43.7xn/a0.2%

4745

Cowealth Medical Holding
NT$24.25-0.6%-8.1%NT$1.9bn/aPE23xn/a6.6%

6747

Brighten Optix
NT$189.000.3%-25.1%NT$4.6bNT$225.95PE22.9xS16.1%2.8%

6841

Ever Fortune.AI
NT$88.304.7%-24.5%NT$8.6bNT$130.00PE62.7xn/a2.3%

6598

Applied BioCode
NT$21.20-0.9%-27.6%NT$1.7bNT$22.00PS4.4xn/an/a

6496

Excelsior Biopharma
NT$28.351.6%-3.6%NT$1.3bn/aPS1.7xn/a0%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.